Lantern Pharma announces expansion of predictBBB.ai into LQM

Lantern Pharma (LTRN) announced the expansion of predictBBB.ai into a Large Quantitative Model- a real-time quantitative intelligence engine now accessible to any researcher or drug development team, anywhere in the world, through a single browser interface. The company said, “For the first time, pharmaceutical scientists and medicinal chemists can access a unified, benchmark-validated LQM – not as a batch software installation, not as a siloed cheminformatics tool – but as an on-demand molecular intelligence engine delivered as a web service. By submitting a single SMILES string, users receive a comprehensive, 360-degree developability profile of any small molecule in seconds: a capability that previously required hours of computation across multiple platforms and specialized bioinformatics personnel to integrate – removing the computational barriers that have historically limited rigorous molecular characterization to large, well-resourced pharmaceutical organizations, and making that same analytical power available to biotech innovators, academic drug hunters, and rare disease programs worldwide.”